Cargando…

Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease

OBJECTIVE: To increase response rates to therapy by increasing the dosage of proton pump inhibitor (PPI) therapy in patients with gastroesophageal reflux disease (GERD) whose symptoms are predominantly associated with acid reflux. METHODS: In this double-blind, randomized, proof-of-concept study, 36...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orlando, Roy C, Liu, Sherry, Illueca, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108657/ https://www.ncbi.nlm.nih.gov/pubmed/21694855 http://dx.doi.org/10.2147/CEG.S12333

Ejemplares similares

Effects of Tegoprazan Versus Esomeprazole on Nighttime Heartburn and Sleep Quality in Gastroesophageal Reflux Disease: A Multicenter Double-blind Randomized Controlled Trial
por: Kim, Joon Sung, et al.
Publicado: (2023)

Dental evaluation is helpful in the differentiation of functional heartburn and gastroesophageal reflux disease
por: Helle, Krisztina, et al.
Publicado: (2023)

Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
por: Gunasekaran, Thirumazhisai, et al.
Publicado: (2009)

A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD)
por: Kalaitzakis, Evangelos, et al.
Publicado: (2007)

Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
por: Cardile, Sabrina, et al.
Publicado: (2012)

Endoscopic-Guided Measurement of Mucosal Admittance can Discriminate Gastroesophageal Reflux Disease from Functional Heartburn
por: Matsumura, Tomoaki, et al.
Publicado: (2017)

Factors associated with dental erosions in gastroesophageal reflux disease: a cross-sectional study in patients with heartburn
por: Picos, Andrei, et al.
Publicado: (2020)

Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients – focus on esomeprazole
por: Tang, Raymond SY, et al.
Publicado: (2013)

Efficacy and Safety of Esomeprazole for the Treatment of Reflux Symptoms in Patients with Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis
por: HOU, Mingxing, et al.
Publicado: (2020)

Management of gastroesophageal reflux disease and erosive esophagitis in pediatric patients: focus on delayed-release esomeprazole
por: Guimarães, Elizabet V, et al.
Publicado: (2010)

Short-Term Symptomatic Relief in Gastroesophageal Reflux Disease: A Comparative Study of Esomeprazole and Vonoprazan
por: Sakurai, Kouichi, et al.
Publicado: (2018)

On-demand versus half-dose continuous therapy with esomeprazole for maintenance treatment of gastroesophageal reflux disease: A randomized comparative study
por: Cho, Joon Hyun, et al.
Publicado: (2018)

Randomized Controlled Trial Comparing the Efficacy of Sustained-Release Formula of Mosapride-Plus-Esomeprazole Combination Therapy to Esomeprazole Monotherapy in Patients with Gastroesophageal Reflux Disease
por: Jeon, Hye Kyung, et al.
Publicado: (2022)

Rabeprazole and esomeprazole in mild-to-moderate erosive gastroesophageal reflux disease: A comparative study of efficacy and safety
por: Maiti, Rituparna, et al.
Publicado: (2011)

Sustained efficacy following resolution of frequent heartburn with an over-the-counter regimen of esomeprazole 20 mg or placebo for 14 days: two randomized trials
por: Peura, David A., et al.
Publicado: (2018)

Distinction between patients with non-erosive reflux disease and functional heartburn
por: Giacchino, Maria, et al.
Publicado: (2013)

Induced Sputum Substance P in Children with Difficult-to-Treat Bronchial Asthma and Gastroesophageal Reflux: Effect of Esomeprazole Therapy
por: Bediwy, Adel Salah, et al.
Publicado: (2011)

Responsiveness of measures of heartburn improvement in non-erosive reflux disease
por: Junghard, Ola, et al.
Publicado: (2007)

Juice Test for Identification of Nonerosive Reflux Disease in Heartburn Patients
por: Fernandes, Michel R, et al.
Publicado: (2018)

Analysis of Clinical Predictors of Resolution of Sleep Disturbance Related to Frequent Nighttime Heartburn and Acid Regurgitation Symptoms in Individuals Taking Esomeprazole 20 mg or Placebo
por: Johnson, David A., et al.
Publicado: (2016)

The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole
por: Degl' Innocenti, Alessio, et al.
Publicado: (2005)

Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease
por: Bayerdörffer, Ekkehard, et al.
Publicado: (2016)

Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study
por: Tolia, Vasundhara, et al.
Publicado: (2010)

Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of Life
por: Takeshima, Fuminao, et al.
Publicado: (2015)

EsReflux Protocol: Epidemiological Study of Heartburn and Reflux-like Symptoms in Spanish Community Pharmacies
por: López-Pintor, Elsa, et al.
Publicado: (2022)

Inconsistency in the Diagnosis of Functional Heartburn: Usefulness of Prolonged Wireless pH Monitoring in Patients With Proton Pump Inhibitor Refractory Gastroesophageal Reflux Disease
por: Penagini, Roberto, et al.
Publicado: (2015)

Pilot, Randomized, Blinded, Placebo-Controlled Trial Investigating the Correlation Between Acid Control and Heartburn Relief with 14 Days of Esomeprazole Treatment
por: Miner, Philip B., et al.
Publicado: (2018)

Prospective Single Arm Study on the Effect of Ilaprazole in Patients with Heartburn but No Reflux Esophagitis
por: Song, In Ji, et al.
Publicado: (2018)

Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease
por: Gold, Benjamin D., et al.
Publicado: (2017)

Comparison of Esophageal Function Tests in Chinese Patients with Functional Heartburn and Reflux Hypersensitivity
por: Gao, Feng, et al.
Publicado: (2017)

First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease
por: Liang, Chih-Ming, et al.
Publicado: (2017)

Lansoprazole plus levosulpiride versus esomeprazole in participants with gastroesophageal reflux disease and erosive esophagitis: a double blinded randomized control trial
por: Umer, Muhammad Rizwan, et al.
Publicado: (2023)

The Relationship between Gastroesophageal Reflux Disease and Chronic Periodontitis
por: Song, Jun Young, et al.
Publicado: (2014)

The Relationship Between White Tongue and Gastroesophageal Reflux Disease
por: Jamali, Raika, et al.
Publicado: (2023)

Obesity and gastroesophageal reflux disease and gastroesophageal reflux symptoms in children
por: Malaty, Hoda M, et al.
Publicado: (2009)

INFLUENCE OF EXERCISE TESTING IN GASTROESOPHAGEAL REFLUX IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE
por: MENDES-FILHO, Antonio Moreira, et al.
Publicado: (2014)

Relationship Between Gastroesophageal Reflux Symptoms and Dietary Factors in Korea
por: Song, Ji Hyun, et al.
Publicado: (2011)

The relationship between gastroesophageal reflux disease and recurrent wheezing in children
por: Lupu, Vasile Valeriu, et al.
Publicado: (2021)

The Relationship between Gastroesophageal Reflux Disease and Chronic Kidney Disease
por: Wang, Xiaoliang, et al.
Publicado: (2023)

A More In-depth Evaluation of Impedance-pH Could Assist in Distinguishing Reflux-related From Reflux-unrelated Heartburn
por: de Bortoli, Nicola, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fu99048e2vmm1vihmhjpvc5nip